Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
3.570
-0.060 (-1.65%)
At close: Oct 6, 2025, 4:00 PM EDT
3.622
+0.052 (1.47%)
After-hours: Oct 6, 2025, 7:58 PM EDT
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $172.46 million as of October 6, 2025. Its market cap has decreased by -88.14% in one year.
Market Cap
172.46M
Enterprise Value
60.08M
1-Year Change
-88.14%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $172.46M, a decrease of -18.88%. That is a compound annual growth rate of -0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 175.36M | 54.44% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | 238.38M | 166.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |